Self-Host
Tools / Inside Trading Tracker
Inside Trading Tracker
Track insider trading activity at publicly traded companies to understand how executives are trading their shares.
Protara Therapeutics Inc. (TARA) Insider Trading Activity
Healthcare • Biotechnology • 26 employees
Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy that is in Phase II clinical trial for patients receiving parenteral nutrition. The company is headquartered in New York, New York.
Total Value
-$184,982.84
Total Shares
86,256
Average Trade Value
-$16,816.62
Most Active Insider
Shefferman Jesse
Total Activity: $113,414
Largest Single Transaction
$73,632
by Shefferman Jesse on Jan 21, 2025
30-Day Activity
0 Transactions
Volume: 0 shares
Value: $0
|
Name
|
Position
|
Date
|
Shares
|
Value
|
Holdings
|
Type
|
|---|---|---|---|---|---|---|
|
CEO and President
|
Jan 24, 2025 | 65,000 | $0 | 994,022 (+6.5%) | Grant | |
|
Vp, Controller
|
Jan 24, 2025 | 9,500 | $0 | 38,942 (+24.4%) | Grant | |
|
Chf Scientific Operations Off
|
Jan 24, 2025 | 24,500 | $0 | 126,639 (+19.3%) | Grant | |
|
Chief Financial Officer
|
Jan 24, 2025 | 23,500 | $0 | 45,500 (+51.6%) | Grant | |
|
Vp, Controller
|
Jan 21, 2025 | 2,130 | $10,139 | 27,312 (-7.8%) | Payment of Exercise Price | |
|
Chf Scientific Operations Off
|
Jan 21, 2025 | 6,554 | $31,197 | 95,585 (-6.9%) | Payment of Exercise Price | |
|
CEO and President
|
Jan 21, 2025 | 15,469 | $73,632 | 913,553 (-1.7%) | Payment of Exercise Price | |
|
Chief Financial Officer
|
Jan 21, 2025 | 3,061 | $14,570 | 18,939 (-16.2%) | Payment of Exercise Price | |
|
CEO and President
|
Jan 3, 2025 | 6,479 | $39,781 | 929,022 (-0.7%) | Payment of Exercise Price | |
|
Vp, Controller
|
Jan 3, 2025 | 394 | $2,419 | 29,442 (-1.3%) | Payment of Exercise Price | |
|
Chf Scientific Operations Off
|
Jan 3, 2025 | 2,157 | $13,244 | 102,139 (-2.1%) | Payment of Exercise Price |